StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.06−0.10 (-3.16%)

Close on Nov 20, 2026Market cap $26.72MP/E –Yield –

BriaCell Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

BriaCell Therapeutics's free cash flow for the twelve months ending Jul 31, 2026 was -$28.78M. For fiscal 2026 it was -$28.78M.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jul 31, 2026-$28.78M–
FY2024Jul 31, 2024-$24.58M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 2026-$5.96M–

More BriaCell Therapeutics figures

See a number that looks wrong?